Go to Making Light's front page.
Forward to next post: What they get up to, in the land of socialized medicine and moose
Subscribe (via RSS) to this post's comment thread. (What does this mean? Here's a quick introduction.)
Yesterday, trying to find out What the Frick the deal was with Teresa not being able to get Cylert any more, I called the FDA. Six levels down in the phone tree I got to a voicemail box, and three hours after that I got a call back.
I talked with a very nice lady whose first, best suggestion was that I get in contact with Public Citizen (!) since they have strong influence on FDA policies. She helpfully gave me their web and email addresses.
I said that Public Citizen was unlikely to be helpful.
Her other suggestion was petitioning the FDA directly.
The one useful bit of information I learned was that there are no open dockets on this drug. I believe opening a docket on it would be a good first step.
Isn’t it astounding that the first-level flack catchers at FDA, as part of their scripts, send folks over to Public Citizen?
Those who wish to repeat the experiment can call the FDA direct at 1-888-INFO-FDA (1-888-463-6332).
If any reporters on deadline want it, I have Dr. Peter Lurie’s direct number here. (If you call his listed number he’s out of the office until mid-January.)
Comments containing more than seven URLs will be held for approval.
If you want to comment on a thread that's been closed, please post to the most recent "Open Thread" discussion.
You can subscribe (via RSS) to this particular comment thread. (If this option is baffling, here's a quick introduction.)
HTML Tags:
<strong>Strong</strong> = Strong
<em>Emphasized</em> = Emphasized
<a href="http://www.url.com">Linked text</a> = Linked text
Spelling reference:
Tolkien. Minuscule. Gandhi. Millennium. Delany. Embarrassment. Publishers Weekly. Occurrence. Asimov. Weird. Connoisseur. Accommodate. Hierarchy. Deity. Etiquette. Pharaoh. Teresa. Its. Macdonald. Nielsen Hayden. It's. Fluorosphere. Barack. More here.
Comments on Strange Advice from the FDA: